baber/WOPTO huggingface dataset:
Patent JP-H024736-B2 (JP)
IPC: E04G1/15
Filed: 1983-04-22
Abstract: PCT No. PCT/SE83/00154 Sec. 371 Date Dec. 9, 1983 Sec. 102(e) Date Dec. 9, 1983 PCT Filed Apr. 22, 1983 PCT Pub. No. WO83/03868 PCT Pub. Date Nov. 10, 1983.A scaffolding system comprises tubular uprights (10) having inwardly extending stiffening and guide flanges (23) for guiding any inserted jointing pieces and braces (15) that may be necessary, and connected with connecting beams (12) by means of bayonet joints (21, 22, 33). Such a bayonet joint comprises a hole (21) in the upright (10) and a locking hook (22) which projects from the end of the beam (12) and which, after it has been turned into its engagement position, is fixed in this position by means of a catch (35) displaceably mounted on the beam for movement into locking engagement with the upright. The inwardly extending stiffening flanges in the tubular uprights have radial recesses provided at a predetermined distance from the ends of the uprights to receive outwardly directed projections on a jointing piece insertable in the uprights.
Patent JP-4160129-B2 (JP)
IPC: H04B7/26
Filed: 1998-03-20
Granted: 2008-10-01
Abstract: The invention relates to a method of channel allocation in a fixed radio link network. For each radio link to be commissioned channels, interference level measurement on each available channel of the frequency band is carried out. Based on the interference measurements, best transmission and reception channel for the link are selected. Thereafter, the radio link can be commissioned and measurements in the next radio link to be commissioned can be started. Instead of using a fixed and pre-set channel for the fixed radio link, a channel is assigned autonomously and automatically when commissioning the link, depending on interference measurement results and/or distance measurement results. The possibility for automatic channel selection decreases the amount of commissioning work by removing the need for detailed frequency planning and fixed channel setting at the factory for each radio.
Patent JP-3665068-B2 (JP)
IPC: A61P15/00
Filed: 1994-07-18
Granted: 2005-06-29
Abstract: Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in further combination with one or more of a cyclooxygenase inhibitor, a PGI2-mimetic, a thromboxane (TXA2) inhibitor, a compound possessing TXA2-agonistic and TXA2-inhibiting properties, a compound possessing TXA2-antagonistic and PGI2-memetic activities, and a TXA2 antagonist.
Patent JP-3015464-B2 (JP)
IPC: C07H19/167
Filed: 1993-07-20
Granted: 2000-03-06
Abstract: Novel 2'-O-alkyl guanosine compounds and analogs thereof are provided. Processes for the preparation of 2'-O-alkyl guanosine and analogs thereof are also provided. Processes for preparing 2'-O-alkylated guanosine, uridine, cytidine, and 2,6-diaminopurine 3'-O-phosphoramidites are also provided. Methods for the use of oligonucleotides comprising 2'-O-alkyl guanosine are also provided.
Patent JP-3005285-B2 (JP)
IPC: A61C5/02
Filed: 1990-05-02
Granted: 2000-01-31
Abstract: Differences in the diameters of successive cutting instruments, either hand- or engine-powered, within sets of instruments described herein progress sequentially by constant percentages of increase, rather than by constant linear increase as is currently the practice in the dental manufacturing industry.
Patent JP-4258025-B2 (JP)
IPC: G06F3/14
Filed: 1997-07-25
Granted: 2009-04-30
Abstract: This IC card reader (1) is intended to release the software workload of a smart IC card (2) which itself supervises the running of its transaction. It is managed by a circuit (14) with microcontroller (140) and memory (141) and includes display means (11). It contains in memory (141) a library of programs which define visual, audio or other objects that are displayed on the display means and are executed by its circuit (14) with microcontroller (140) and memory (141) in response to a call from the connected IC card (2). By virtue of this library of programs, the IC card reader (1) provides a connected IC card (2) with a particularly sophisticated man-machine interface accessible using simplified commands. The object program calls are advantageously accompanied by parameters allowing the way in which the objects are defined and animated to be adjusted at leisure.
Patent JP-3993639-B2 (JP)
IPC: C08G63/80
Filed: 1997-07-28
Granted: 2007-10-17
Abstract: An improved process for preparing high molecular weight polyester polymers, such as poly(butylene terephthalate), an alkylene glycol and a di- or tricarboxylic acid by first preparing a pre-polymer in the form of uniform solid particles having an intrinsic viscosity of from 0.1 to about 0.3 dL/gm and a chemical composition which contains greater than a 1% stoichiometric excess of the alkylene glycol above the amount required to produce a high molecular weight polymer, and polymerizing the pre-polymer in the solid state.
Patent JP-3650112-B2 (JP)
IPC: F02C7/18
Filed: 1994-09-19
Granted: 2005-05-18
Abstract: A combined gas-turbine and steam-turbine plant includes waste-heat steam generator which is located downstream of the gas turbine. The heating surfaces of the waste-heat steam generator are connected in a water/steam loop of the steam turbine. The gas turbine is cooled and the heat obtained in that heat exchange is further utilized. An intermediate circuit is linked to a first heat exchanger which cools the coolant of the gas turbine and to a second heat exchanger which is connected in the water/steam loop.
Patent JP-3703852-B2 (JP)
IPC: B65D81/32
Filed: 1997-08-27
Granted: 2005-10-05
Abstract: PCT No. PCT/EP97/04659 Sec. 371 Date Aug. 9, 1999 Sec. 102(e) Date Aug. 9, 1999 PCT Filed Aug. 27, 1997 PCT Pub. No. WO98/09886 PCT Pub. Date Mar. 12, 1998A container system includes two closable containers for containing two substances, respectively, whereby the closable containers are joined together in their closed form with their respective closures facing each other. By moving the joined containers relative to one another, the closures between the containers can be opened in such a way that their contents can be brought together and mixed. After mixing, the mixture can then be dispensed from one of the containers.
Patent JP-4097696-B2 (JP)
IPC: B29C48/94
Filed: 1996-09-20
Granted: 2008-06-11
Abstract: PCT No. PCT/SE96/01169 Sec. 371 Date Mar. 20, 1998 Sec. 102(e) Date Mar. 20, 1998 PCT Filed Sep. 20, 1996 PCT Pub. No. WO97/10936 PCT Pub. Date Mar. 27, 1997The invention relates to a process for heating polymer material, including irradiation of said polymer material with infrared radiation. In accordance with the process according to the invention the infrared radiation has wave lengths which substantially are not equal to the absorption peaks of the polymer material in respect of infrared radiation.
Patent JP-3935937-B2 (JP)
IPC: A61B5/05
Filed: 1996-09-25
Granted: 2007-06-27
Abstract: The invention relates to an apparatus for the in vivo non-invasive measurement of a biological parameter concerning a bodily fluid of a person or animal in accordance with a calculation model, wherein the apparatus is provided with connections for at least two pairs of electrodes (2-5, 8-11) to be placed on the skin of a part of the body, a pair of input electrodes (2, 3, 8, 9) for feeding a measuring alternating current to the part of the body and a measuring pair of electrodes (4, 5, 10, 11) for measuring the voltage at the measuring pair of electrodes, comprising a current source (7, 12) providing the measuring alternating current, a transformer (31) for the transformation of the measuring voltage into a bio-impedance signal, being a measure of the bio-impedance of the part of the body, and means for the generation of signals which form a measure for further parameters to be determined with the aid of the calculating model, said signals encompassing a signal forming a measure for the time derivative of the bio-impedance signal. The current source (7, 12) has a minimal radiation configuration and is suitable for generating a measuring current having a constant amplitude on at least two frequencies, a low frequency and a high frequency, in a frequency range of up to about 2000 kHz.
Patent JP-3703145-B2 (JP)
IPC: C12Q1/58
Filed: 1993-11-12
Granted: 2005-10-05
Abstract: PCT No. PCT/DE93/01085 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Nov. 12, 1993 PCT Pub. No. WO94/13830 PCT Pub. Date Jun. 23, 1994A device for carrying out urease tests for combined antrum/corpus biopsies to diagnose gastro-intestinal illnesses has a carrier plate, a schematic representation of the stomach on the plate, at least one opening in the plate at the locations corresponding to the corpus and the antrum in the schematic representation of the stomach, an evaluation scale for assessment of the urease test and an area for data on the patient and for clinical data.
Patent JP-3968125-B2 (JP)
IPC: A61K8/00
Filed: 1995-11-02
Granted: 2007-08-29
Abstract: Stable, sprayable compositions suitable for topical application to human skin or hair are provided, along with a method for their preparation. The compositions comprise water-in-oil emulsions and a variety of substantially insoluble dispersed powder. The compositions are useful for applying color to human skin or hair, for protecting human skin from ultraviolet radiation, and for treating human skin or hair with a dermatologically active agent. The compositions have unique suspending power, stability and dispersibility for water-in-oil emulsions.
Patent JP-3778927-B2 (JP)
IPC: C07J9/00
Filed: 1994-10-27
Granted: 2006-05-24
Abstract: The present invention is a process for the conversion of bisnoralcohol (I) to bisnoraldehyde (II) which is a known intermediate in the synthesis of progesterone.
Patent JP-2702288-B2 (JP)
IPC: B67D1/08
Filed: 1995-02-07
Granted: 1998-01-21
Abstract: PCT No. PCT/DK95/00057 Sec. 371 Date Jan. 3, 1996 Sec. 102(e) Date Jan. 3, 1996 PCT Filed Feb. 7, 1995 PCT Pub. No. WO95/21120 PCT Pub. Date Aug. 10, 1995A sealing ring is placed in a container device which serves the purpose of distributing a liquid, e.g. draught beer, which is stored in a container under pressure of a gas, e.g. CO2. In a threaded neck ring on the container a valve is threadingly retained. The valve is a combined gas- and liquid valve with passages for gas as well as liquid. On the valve and the neck ring planar, parallel, opposite ring faces are formed between which the sealing ring. From the ring face of the valve, a cylindrical projection protrudes and extends downwards to the ring face of the neck ring. Between the valve and the neck ring there is a slot space through which an overpressure in the container can be relieved when the valve is being dismounted. The projection serves the purpose of preventing this slot space from being closed for flow of gas by some of the sealing ring which is squeezed up into the space by the gas overpressure and preventing this space from being relieved, so that an operator, when dismounting a valve is exposed to the risk of being hit by the valve, if this, by the gas overpressure, is being thrown out into the room in the very moment when the valve releases its engagement with the neck ring.
Patent JP-4223546-B2 (JP)
IPC: G01N33/542
Filed: 1994-04-07
Granted: 2009-02-12
Abstract: The present invention relates to methods for immunoassay of analytes employing mutant glucose-6-phosphate dehydrogenase (G6PDH) enzymes as labels. In particular, the invention relates-to the use of conjugates of an analyte or analyte analog and a mutant NAD+ dependent G6PDH differing from any precursor G6PDH by the deletion, substitution, or insertion, or any combination thereof of at least one amino acid per subunit. The invention also involves the construction of several mutations in precursor glucose-6-phosphate dehydrogenase (G6PDH) enzymes. Typically, the mutations involve deletion or substitution of one or more lysine residues, or introduction of one or more cysteine residues by insertion of cysteine to precursor G6PDH or substitution of precursor G6PDH amino acids residues with cysteine. The present invention also relates to conjugates of the subject enzymes and specific binding pair members, kits useful in performing the methods of the invention, cell lines producing the subject enzymes, DNA sequences encoding the subject enzymes, and vectors containing DNA encoding the subject enzymes and designed to allow a host cell to produce the subject enzymes.
Patent JP-2750222-B2 (JP)
IPC: C12P19/62
Filed: 1995-01-19
Granted: 1998-05-13
Abstract: A new process for recovering high purity natamycin from fermentation broth containing natamycin comprises the steps of adjusting the pH of the broth to above about 10 and adding an amount of a water-miscible solvent, such as isopropanol, sufficient to dissolve the natamycin in the broth, followed by removing insoluble solids from the pH-adjusted broth, followed by lowering the pH of the broth to a level sufficient to precipitate the natamycin, and removing the natamycin from the broth.
Patent JP-3058448-B2 (JP)
IPC: G08B25/04
Filed: 1995-04-06
Granted: 2000-07-04
Abstract: PCT No. PCT/FR95/00442 Sec. 371 Date May 1, 1996 Sec. 102(e) Date May 1, 1996 PCT Filed Apr. 6, 1995 PCT Pub. No. WO95/27929 PCT Pub. Date Oct. 19, 1995A system monitor sensors which control actuating elements in a building. The supervision unit essentially collects information from the sensors and controls the actuating elements. A precable system in the building connects the supervision unit to input/output connections of a plurality of interconnection devices. The plurality of interconnection devices each include a plurality of terminal boards connected to the sensors and actuating elements through a first set of cables. A microprocessor has a portion of the I/O connections connected to the terminal board through a second set of cables, transmitting signals between the actuating elements, sensors and the supervision unit.
Patent JP-4065029-B2 (JP)
IPC: C08G18/42
Filed: 1997-12-12
Granted: 2008-03-19
Abstract: This invention relates to a binder composition suitable for coating compositions, which binder composition contains one or more carboxy-functional polymers, one or more compounds having an epoxide function in the molecule, one or more polyols having at least two hydroxyl functions in the molecule, which polyols differ from a component A) optionally containing hydroxyl functions, components which crosslink with hydroxyl groups to form ethers and/or a triazine-based crosslinking agent, optionally one or more polyisocyanates, which may optionally be capped, optionally an anhydride component and optionally one or more catalysts for catalysing the reaction of carboxyl and epoxide groups.
Patent JP-4110297-B2 (JP)
IPC: H01M50/414
Filed: 1997-03-27
Granted: 2008-07-02
Abstract: The mixture (I) contains a mixture (II) consisting of: (a) 1-95 wt.% of a solid (III) having a primary particle size of 0.01-10 mu m; and (b) 5-99 wt.% of a polymeric composition (IV) obtained by polymerising: (b1) 5-100 wt.% of an ester (V) made of a multivalent alcohol (VI) containing carbon and oxygen atoms in the main chain, and at least one molecule per molecule alcohol (VI) of an  alpha - beta  unsaturated carboxylic acid (VII); and (b2) 0-95 wt.% of a further compound (VIII) having an average molecular weight of ≥ 5000 with polyether segments in main and side chains. The weight of mixture (II) to mixture (I) is 35-100 wt.%.
Patent JP-4584363-B2 (JP)
IPC: A61P35/02
Filed: 1998-03-17
Granted: 2010-11-17
Abstract: B-Cell malignancies, such as the B-cell subtype of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, are significant contributors to cancer mortality. The response of B-cell malignancies to various forms of treatment is mixed. Traditional methods of treating B-cell malignancies, including chemotherapy and radiotherapy, have limited utility due to toxic side effects. Immunotherapy with anti-CD20 antibodies have also provided limited success. The use of antibodies that bind with the CD22 antigen, however, provides an effective means to treat B-cell malignancies such as indolent and aggressive forms of B-cell lymphomas, and acute and chronic forms of lymphatic leukemias. Moreover, immunotherapy with anti-CD22 antibodies requires comparatively low doses of antibody protein, and can be used effectively in multimodal therapies.
Patent PL-157701-B2 (PL)
Title: Method for and device for concrete laying
IPC: B28B/
Filed: 1989-02-13
Abstract: A method for building massive, large-size concrete or reinforced-concrete structures in watered ground or under water, by arranging large stones or reinforcement and stones in a prepared shuttering or trench, filling voids with a composition comprising cement, sand with grain size up to 2 mm, water and plastifiers by means of injection tubes, wherein the voids are filled with an activated composition which is prepared by disintegration mixing of the mixture in a mixing device comprising a turbine rotor with blades, the said rotor being used at the rate of 4000 rpm or higher.<IMAGE>
Patent AU-2001273109-B2 (AU)
Title: Rho-isoalpha acid hop products and methods
Inventor: WILSON RICHARD J H
IPC: C12C5/02
Filed: 2001-06-29
Granted: 2006-06-08
Abstract: Aqueous concentrated compositions of an alkali metal salt of rho-iso-±-acids for use as brewing additive are prepared by mixing alkali
Patent AU-2001273303-B2 (AU)
Title: Use of 2alpha-methyl-19-nor-20(s)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
Inventor: SMITH CONNIE M
IPC: A61K31/59
Filed: 2001-07-10
Granted: 2006-02-02
Abstract: This invention provides pharmaceutical uses for 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D<SUB>3</SUB>. This compound is characterized by high bone calcium mobilization activity demonstrating preferential activity on bone. This results in a novel therapeutic agent for the treatment of diseases where bone formation is desired, particularly osteoporosis. This compound also exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis. This compound also increases both breaking strength and crushing strength of bones evidencing use in conjunction with bone replacement surgery such as hip and knee replacements.
Patent AU-2002243390-B2 (AU)
Title: Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
Inventor: MAES DANIEL H
IPC: A61K31/7008
Filed: 2001-12-20
Granted: 2006-03-02
Abstract: The present invention provides compositions containing a mixture of cholesterol sulfate and an exfoliant. The exfoliant can be N-acetyl-D-glucosamine, N-acetylgalactosamine, or a combination thereof. The combination of cholesterol sulfate with the exfoliant surprisingly enhances the skin barrier even though the activity of each of the components is opposite the other. In addition, because of the ability to enhance or repair the skin barrier function, methods of maintaining or improving a healthy skin barrier are included in the present invention by apply to the skin an effective amount of the mixture of cholesterol sulfate with the exfoliant. The mixture can also be useful in treating or preventing damage to the skin, where the damage is caused by a comprised skin barrier function. As a result of improved skin barrier function, the appearance of lines and wrinkles is generally reduced; rough and dry skin conditions are also improved.
Patent AU-2002257145-B2 (AU)
Title: Method for lowering serum glucose
Inventor: BURKE STEVEN K
IPC: A61K31/78
Filed: 2002-04-10
Granted: 2005-06-02
Abstract: A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the invention include sevelamer hydrogen chloride and colesevelam. The invention includes the use of amine polymers such as a cross-linked polymer characterized by a repeat unit having the formula: and salts and copolymers thereof, where n is a positive integer and x is zero or an integer between 1 and about 4. Also described is a use, for the manufacture of a medicament, of a polymer that lowers serum glucose.
Patent AU-2002301974-B2 (AU)
Title: Method of, and Apparatus for, Conveying Sheet-like Products
Inventor: HONEGGER WERNER
IPC: B65H29/04
Filed: 2002-11-13
Granted: 2008-11-20
Abstract: The conveying process involves gripping the products (10,10') at their leading edges at their leading edges to pass them to at least one conveying device (2) in at least one transfer point so that each product at least partly overlaps the previous one. The leading edges (10a,10a') of the products are spaced out from each other.
Patent AU-2002346964-B2 (AU)
Title: Comminution machine
Inventor: PIZZUTO GIANFRANCO
IPC: A01B33/16
Filed: 2002-10-07
Granted: 2008-04-10
Abstract: A comminution machine included in an earth working machine which can be moved over a terrestrial area to be worked in a direction of working comprises a rotating roller comminution device. A grader blade is mounted on the comminution machine down stream from the comminution device in the direction of working.
Patent AU-2002347239-B2 (AU)
Title: Method, system and component for controlling preservation of a product
Inventor: VAILLANT RENAUD
IPC: G01K3/04
Filed: 2002-09-16
Granted: 2008-04-03
Abstract: The invention pertains to a method, a system and a component for systematically and automatically controlling a product, whose preservation in a distribution circuit depends on temperature, in particular a product subjected to a cold chain. The method includes: affixing, on the product, a marker including elements, in particular the bars of a bar code, intended to be identified by automatic processing units, fixing a component on the product. The component includes at least one part including a mask intended for masking the elements of the marker, at least temporarily, without modifying them, when (i) the temperature of the product exceeds a specific temperature threshold or (ii) when the preservation conditions differ from a specific reference level, in particular characterized by the exceeding of a specific temperature threshold for a longer duration than a specific duration or by the exceeding of a specific preservation duration.
Patent AU-2003204529-B2 (AU)
Title: Shutoff device for burners of a pulverized coal furnace
Inventor: LEISSE ALFONS
IPC: F23K3/02
Filed: 2003-06-03
Granted: 2008-05-29
Abstract: Shut-off device for pulverized coal burners of a pulverized coal furnace comprises a stop valve (17) provided with a slide plate (18) arranged in a feed line (15) to close the feed line. The feed line is tightly connected to an air receiver (23) on the downstream-side of the stop valve. An opening (25) closed by a closing plate (26) is located in the wall of the feed line in the region of the air receiver. The closing plate operates synchronously with the stop valve so that the opening is released when the stop valve is closed and the opening is closed when the stop valve is open.  Preferred Features: The air receiver tightly surrounds the feed line on all sides on the downstream-side of the stop valve.
Patent AU-2003251971-B2 (AU)
Title: Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Inventor: POPE LAURA E
IPC: A61K31/4745
Filed: 2003-07-17
Granted: 2008-02-21
Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
Patent AU-2003258697-B2 (AU)
Title: Conjugated hydroxyalkyl starch allergen compounds
Inventor: EICHNER WOLFRAM
IPC: A61K47/48
Filed: 2003-09-02
Granted: 2009-07-23
Abstract: Conjugates (I) of hydroxyalkyl starch (HAS) with allergens (A), in which at least one HAS is covalently bonded to the allergen, are new.